CA2063988A1 - Derives du tetrahydrobenzothiazole pour le traitement des maladies de l'oeil - Google Patents

Derives du tetrahydrobenzothiazole pour le traitement des maladies de l'oeil

Info

Publication number
CA2063988A1
CA2063988A1 CA002063988A CA2063988A CA2063988A1 CA 2063988 A1 CA2063988 A1 CA 2063988A1 CA 002063988 A CA002063988 A CA 002063988A CA 2063988 A CA2063988 A CA 2063988A CA 2063988 A1 CA2063988 A1 CA 2063988A1
Authority
CA
Canada
Prior art keywords
group
amino
tetrahydro
benzothiazole
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002063988A
Other languages
English (en)
Inventor
Joachim Leonard
Christian Schilling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2063988A1 publication Critical patent/CA2063988A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002063988A 1989-07-18 1990-07-14 Derives du tetrahydrobenzothiazole pour le traitement des maladies de l'oeil Abandoned CA2063988A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3923689.7 1989-07-18
DE3923689A DE3923689A1 (de) 1989-07-18 1989-07-18 Neue verwendung von tetrahydrobenzthiazolderivaten als arzneistoffe

Publications (1)

Publication Number Publication Date
CA2063988A1 true CA2063988A1 (fr) 1991-01-19

Family

ID=6385257

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002063988A Abandoned CA2063988A1 (fr) 1989-07-18 1990-07-14 Derives du tetrahydrobenzothiazole pour le traitement des maladies de l'oeil

Country Status (8)

Country Link
EP (1) EP0483252A1 (fr)
KR (1) KR927003051A (fr)
AU (1) AU6149690A (fr)
CA (1) CA2063988A1 (fr)
DD (1) DD298395A5 (fr)
DE (1) DE3923689A1 (fr)
HU (1) HUT60922A (fr)
WO (1) WO1991001136A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008308488A (ja) * 2007-05-11 2008-12-25 Santen Pharmaceut Co Ltd 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004409A2 (fr) * 2000-07-06 2002-01-17 Us Gov Health & Human Serv Agents neuroprotecteurs à base d'analogues de tétrahydrobenzothiazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4400378A (en) * 1981-11-02 1983-08-23 Karl Thomae Gesellschaft Mit Beschrankter Haftung Pharmaceutical composition for the treatment of glaucoma
EP0186087B1 (fr) * 1984-12-22 1989-08-23 Dr. Karl Thomae GmbH Tétrahydro-benzothiazoles, leur procédé de préparation et leur utilisation comme intermédiaires ou médicaments

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008308488A (ja) * 2007-05-11 2008-12-25 Santen Pharmaceut Co Ltd 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤

Also Published As

Publication number Publication date
EP0483252A1 (fr) 1992-05-06
KR927003051A (ko) 1992-12-17
HUT60922A (en) 1992-11-30
AU6149690A (en) 1991-02-22
DE3923689A1 (de) 1991-01-24
HU9200150D0 (en) 1992-04-28
WO1991001136A1 (fr) 1991-02-07
DD298395A5 (de) 1992-02-20

Similar Documents

Publication Publication Date Title
EP2026803B1 (fr) Compositions de r(+) et s(-) pramipéxole et procédés d'utilisation de celles-ci
EP0236684B1 (fr) Galanthamine ou ses analogues pour le traitement de la maladie d'Alzheimer
CA2414774C (fr) Utilisation d'agonistes du recepteur d2/d3 de la dopamine destine au traitement de la fibromyalgie
WO2002096318A2 (fr) Methode de traitement du glaucome
EP2497472A1 (fr) Quantités thérapeutiquement efficaces de R(+) et S(-) pramipexole pour une utilisation dans le traitement de la maladie de Parkinson et leurs compositions pharmaceutiques
MX2013003004A (es) Profarmacos de ester de [3-(1h-imidazol-4-il)etil)-2-metilfenil]me tanol para disminuir la presion intraocular.
DE69721824T2 (de) Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
JP4306825B2 (ja) インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
JP4450456B2 (ja) 皮脂産生抑制剤
US6329407B1 (en) Use of polycyclic thiazole systems for the treatment of obesity
WO2005079792A1 (fr) Agents préventifs ou thérapeutiques pour la rétinopathie diabétique sévère
HU219482B (hu) (+)Doxazoszin alkalmazása vizeletfolyást fokozó gyógyászati készítmények előállítására
KR100471351B1 (ko) 당뇨병성 합병증의 예방·치료제
CA2063988A1 (fr) Derives du tetrahydrobenzothiazole pour le traitement des maladies de l'oeil
JP2003201255A (ja) アルツハイマー病予防および治療剤
JP2020514347A (ja) チオトロピウムを有効成分として含有する近視予防、近視治療および／または近視進行抑制剤
HUT50439A (en) Process for production of medical compositions suitable for treatment of sleep-disturbances and depression
EP0443028A1 (fr) Agent carcinostatique non injecte permettant de supprimer l'inflammation due a 5-fluorouracil, et procede de traitement du cancer
JP3066561B2 (ja) 近視予防・治療剤
EP0002051B1 (fr) L'utilisation du bromure de butoxybenzylhyoscyamine dans des compositions pharmaceutiques contre la surdité et le tinnitus
JP2761104B2 (ja) 脊髄小脳変性症治療剤
JPH08500120A (ja) 置換アザスピランを用いる乾癬の治療方法
JPH0317016A (ja) 神経系症状の処置剤
CN112402408A (zh) 盐酸丙美卡因及其衍生化合物在制备预防和/或治疗癫痫药物中的应用
EP0397437A1 (fr) Méthode pour le traitement des yeux humains et composition à cette fin

Legal Events

Date Code Title Description
FZDE Dead